KAYLA SUBER: Open Payments
NPI 1124530001 · CHILLICOTHE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 7 payments from 5 companies in 2025. Trend: 2023 $302 · 2024 $162 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: INGREZZA, OTEZLA, REXULTI, REPATHA, Wegovy, GEMTESA.
Industry payments across MO — which companies pay providers there.
